The new announcements bring the number of IPOs priced this week to four, coming shortly after South San Francisco ...

Acute pancreatitis is linked to the development of gallstones, which are listed as a side effect with GLP-1 drugs. Ahmed said ...

The Pfizer Foundation recently announced a new three-year, $10 million investment through its Action & Impact: A Cancer Care ...

"EMA will now review all available data to assess whether this emerging information has an impact on the balance of benefits and risks of Tavneos," said the EU regulator. "The agency will then issue a ...

By rethinking creative as an interactive educational experience, and not just a promotional message, pharmaceutical brands ...

Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, ...

The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...

That is according to the Wall Street Journal, which has said MSD failed to reach an agreement with Revolution on a fair price ...

At Lineage Cell Therapeutics, CEO Brian Culley has been working for many years on allogeneic cell therapies across a range of ...

At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap ...

The South San Francisco start-up is offering 17.6 million shares at a price range of $16 to $18, which would give the company ...

Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus (HDV), ...